We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$16.8B
AUM Growth
+$94M
(+0.56%)
Cap. Flow
-$533M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
17.18%
Holding
362
New
38
Increased
90
Reduced
146
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$166M |
| 2 |
Trane Technologies
TT
|
+$136M |
| 3 |
Estee Lauder
EL
|
+$102M |
| 4 |
Celanese
CE
|
+$101M |
| 5 |
Oracle
ORCL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$172M |
| 2 |
ARTC
ARTHROCARE CORP
ARTC
|
+$118M |
| 3 |
eBay
EBAY
|
+$109M |
| 4 |
Ecolab
ECL
|
+$107M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$86.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Industrials | 14.66% |
| 3 | Technology | 14.16% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $404M | 2.4% |
17,387,504
-3,000,528
| -15% | -$63.9M |
|
2
Alphabet (Google) Class C
GOOG
$3.89T
| $386M | 2.3% |
13,342,512
-447,543
| -3% | -$12.1M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $351M | 2.09% |
4,084,283
-216,665
| -5% | -$16.5M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $324M | 1.93% |
1,453,962
-41,428
| -3% | -$8.58M |
|
5
Jazz Pharmaceuticals
JAZZ
$16B
| $279M | 1.66% |
1,894,721
+384,791
| +25% | +$53.4M |
|
6
Teva Pharmaceuticals
TEVA
$36.3B
| $271M | 1.61% |
5,168,554
+256,191
| +5% | +$13.1M |
|
|
ANDV
7
DELISTED
Andeavor
ANDV
| $227M | 1.35% |
3,861,562
+448,381
| +13% | +$24.7M |
|
|
CBST
8
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $226M | 1.34% |
3,234,570
+536,335
| +20% | +$36.5M |
|
9
Thermo Fisher Scientific
TMO
$213B
| $219M | 1.3% |
1,854,438
-123,466
| -6% | -$14.5M |
|
10
Comcast
CMCSA
$78.3B
| $201M | 1.2% |
7,499,720
+761,676
| +11% | +$19.6M |
|
11
Cooper Companies
COO
$13.7B
| $198M | 1.18% |
5,857,036
+211,184
| +4% | +$6.98M |
|
12
Booking.com
BKNG
$134B
| $197M | 1.17% |
4,095,300
-143,300
| -3% | -$6.88M |
|
|
TYC
13
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $193M | 1.15% |
4,046,621
-46,421
| -1% | -$2.09M |
|
14
Ametek
AME
$55.3B
| $188M | 1.12% |
3,588,446
-7,260
| -0.2% | -$381K |
|
15
Salesforce
CRM
$129B
| $186M | 1.11% |
3,205,835
+156,405
| +5% | +$8.45M |
|
16
Meta Platforms (Facebook)
META
$1.54T
| $185M | 1.1% |
2,745,543
+249,073
| +10% | +$15.3M |
|
17
Halliburton
HAL
$27.3B
| $183M | 1.09% |
2,580,348
-87,127
| -3% | -$5.58M |
|
18
NOV
NOV
$7.22B
| $181M | 1.08% |
2,201,281
+170,228
| +8% | +$12.7M |
|
|
VIAB
19
DELISTED
Viacom Inc. Class B
VIAB
| $180M | 1.07% |
2,077,652
+302,887
| +17% | +$25.7M |
|
|
MON
20
DELISTED
Monsanto Co
MON
| $176M | 1.05% |
1,414,730
-34,629
| -2% | -$4.05M |
|
|
21
Verizon
VZ
$183B
| $169M | 1.01% |
3,461,724
+3,427,710
| +10,077% | +$166M |
|
|
22
Oracle
ORCL
$346B
| $167M | 1% |
4,129,526
+1,641,283
| +66% | +$67.5M |
|
23
Visa
V
$669B
| $166M | 0.99% |
3,153,344
-875,740
| -22% | -$45.8M |
|
24
CNX Resources
CNX
$4.88B
| $160M | 0.95% |
4,169,359
-421,617
| -9% | -$15.5M |
|
25
American International
AIG
$41.4B
| $160M | 0.95% |
2,923,532
-395,429
| -12% | -$20.9M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Westfield Capital Management held 362 positions worth $16.8B, up 0.56% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $533M in Q2 2014, closing 50 positions and reducing 146 holdings. Its most notable exit was ARTHROCARE CORP, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
Against the trend, Westfield Capital Management opened a new position in Trane Technologies worth $143M.
- Westfield Capital Management's largest Q2 2014 buy was Trane Technologies: 2,294,021 shares worth $143M.
- Westfield Capital Management added most to Verizon in Q2 2014, an estimated $166M increase.
- Westfield Capital Management's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $172M.
- Westfield Capital Management fully exited ARTHROCARE CORP in Q2 2014, selling an estimated $118M.
- Westfield Capital Management's ten largest holdings make up 17% of its $16.8B portfolio in Q2 2014.
- Westfield Capital Management opened 38 new positions and closed 50 in Q2 2014.
- Westfield Capital Management's portfolio value rose 0.56% quarter-over-quarter to $16.8B.
Based on Westfield Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.